185 related articles for article (PubMed ID: 38528259)
1. Establishment and characterization of cytochrome P450 1A1 CRISPR/Cas9 Knockout Bovine Foetal Hepatocyte Cell Line (BFH12).
Iori S; D'Onofrio C; Laham-Karam N; Mushimiyimana I; Lucatello L; Lopparelli RM; Gelain ME; Capolongo F; Pauletto M; Dacasto M; Giantin M
Cell Biol Toxicol; 2024 Mar; 40(1):18. PubMed ID: 38528259
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of cytochrome P450 3A74 CRISPR/Cas9 knockout bovine foetal hepatocyte cell line (BFH12).
Iori S; D'Onofrio C; Laham-Karam N; Mushimiyimana I; Lucatello L; Montanucci L; Lopparelli RM; Bonsembiante F; Capolongo F; Pauletto M; Dacasto M; Giantin M
Biochem Pharmacol; 2024 Jun; 224():116231. PubMed ID: 38648904
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Novel
Sun D; Lu J; Zhang Y; Liu J; Liu Z; Yao B; Guo Y; Wang X
Drug Metab Dispos; 2021 Aug; 49(8):638-647. PubMed ID: 34074728
[TBL] [Abstract][Full Text] [Related]
4. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
[TBL] [Abstract][Full Text] [Related]
5. Effects of fenbendazole and triclabendazole on the expression of cytochrome P450 1A and flavin-monooxygenase isozymes in bovine precision-cut liver slices.
Maté L; Giantin M; Viviani P; Ballent M; Tolosi R; Lifschitz A; Lanusse C; Dacasto M; Virkel G
Vet J; 2019 Mar; 245():61-69. PubMed ID: 30819427
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of Sunitinib on the Expression Profiles of Xenobiotic-Metabolizing Enzymes and Transporters in Rat Liver and Kidneys.
Korashy HM; Ansari MA; Maayah ZH; Imam F; Raish M; Attafi IM; Alharbi NO; Moraished BA
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):173-83. PubMed ID: 26797788
[TBL] [Abstract][Full Text] [Related]
7. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
Schulz C; Kammerer S; Küpper JH
Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
[TBL] [Abstract][Full Text] [Related]
8. Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model.
Lu J; Chen A; Ma X; Shang X; Zhang Y; Guo Y; Liu M; Wang X
Drug Metab Dispos; 2020 Nov; 48(11):1129-1136. PubMed ID: 32878767
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of human embryonic stem cell-derived hepatocyte-like cells for detection of CYP1A inducers.
Tsuchiya H; Matsunaga T; Aikawa K; Kamada N; Nakamura K; Ichikawa H; Sasaki K; Ohmori S
Drug Metab Pharmacokinet; 2012; 27(6):598-604. PubMed ID: 22673034
[TBL] [Abstract][Full Text] [Related]
10. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line.
Hukkanen J; Lassila A; Päivärinta K; Valanne S; Sarpo S; Hakkola J; Pelkonen O; Raunio H
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):360-6. PubMed ID: 10696073
[TBL] [Abstract][Full Text] [Related]
11. Functional cytochrome P450 1A enzymes are induced in mouse and human islets following pollutant exposure.
Ibrahim M; MacFarlane EM; Matteo G; Hoyeck MP; Rick KRC; Farokhi S; Copley CM; O'Dwyer S; Bruin JE
Diabetologia; 2020 Jan; 63(1):162-178. PubMed ID: 31776611
[TBL] [Abstract][Full Text] [Related]
12. Synergistic induction of drug-metabolizing enzymes in co-cultures of bovine hepatocytic and sinusoidal cell lines.
Yoshioka M; Takenouchi T; Kitani H; Guruge KS; Yamanaka N
In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):2-9. PubMed ID: 31722089
[TBL] [Abstract][Full Text] [Related]
13. Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.
Walsh AA; Szklarz GD; Scott EE
J Biol Chem; 2013 May; 288(18):12932-43. PubMed ID: 23508959
[TBL] [Abstract][Full Text] [Related]
14. Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells.
Heintze T; Klein K; Hofmann U; Zanger UM
Sci Rep; 2021 Jan; 11(1):1000. PubMed ID: 33441761
[TBL] [Abstract][Full Text] [Related]
15. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
17. Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2?
Liu N; Zhang QY; Vakharia D; Dunbar D; Kaminsky LS
Arch Biochem Biophys; 2001 May; 389(1):130-4. PubMed ID: 11370663
[TBL] [Abstract][Full Text] [Related]
18. Effect of pyridine on the expression of cytochrome P450 isozymes in primary rat hepatocyte culture.
Wu D; Ramin SA; Cederbaum AI
Mol Cell Biochem; 1997 Aug; 173(1-2):103-11. PubMed ID: 9278260
[TBL] [Abstract][Full Text] [Related]
19. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.
Garcia M; Rager J; Wang Q; Strab R; Hidalgo IJ; Owen A; Li J
In Vitro Cell Dev Biol Anim; 2003; 39(7):283-7. PubMed ID: 14599235
[TBL] [Abstract][Full Text] [Related]
20. Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.
Stiborová M; Levová K; Bárta F; Shi Z; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Arlt VM
Toxicol Sci; 2012 Feb; 125(2):345-58. PubMed ID: 22086975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
